• AZAZ
  • RURU
AEM
+994 12 596 05 20
Write us
No Result
View All Result
  • About Us
  • Import
    • Documents
    • Letter samples
  • Control
    • Control on Medicines
    • Legislation
  • Registration
    • Department of Registration
    • Legislation
  • Laboratory
    • About the Quality Control Laboratory
  • Pharmacovigilance
    • General information
    • Legislation
    • Information for healthcare professionals
    • Information for Patients
    • Pharmacovigilance dictionary
    • Reporting forms
    • Online reporting
    • For MAH
    • Medicines under additional monitoring
  • Private medical institutions
    • Legislation
  • FS
    • Expertise of FS
    • Result of the Expertise of FS
  • Medical devices
    • Application form
    • MD Documents
    • Results of examination of medical devices
    • Legislation
  • MD monitoring
    • Tracking and Tracing of Medicines Department
AEM
No Result
View All Result

A decision has been made to voluntarily recall two medicinal products

July 31, 2025
A A

On July 23, 2025, Zeytun Pharmaceuticals LLC submitted a request to the Analytical Expertise Center under the Ministry of Health for the voluntary recall of two medicinal products. The details are as follows:

  1. Paracetamol – 125 mg/supp., trade name “Para-Denk 125 Suppos”, rectal suppositories, pack of 10 (2×5) in blisters, in a cardboard box. The marketing authorization holder is Denk Pharma GmbH Ko.KG / Germany. The damaged batches are:
    • Batch No. 27339, expiry date: 31.03.2026
    • Batch No. 27839, expiry date: 01.08.2026
    • Batch No. 26906, expiry date: 31.07.2025
  2. Paracetamol – 250 mg/supp., trade name “Para-Denk 250 Suppos”, rectal suppositories, pack of 10 (2×5) in blisters, in a cardboard box. The marketing authorization holder is Denk Pharma GmbH Ko.KG / Germany. The damaged batches are:
    • Batch No. 27292, expiry date: 28.02.2026
    • Batch No. 27822, expiry date: 30.06.2026

The reason for the recall is packaging defects (leakages).
The recall classification has been determined as Class 3 (where the defect is unlikely to cause harm to a person’s health),
and the recall level as Level C (up to the wholesale distributor level).

The stated defects were confirmed during inspection in both products.

In accordance with the “Rules for the Recall of Medicinal Products,” approved by the Decision No. 460 of the Cabinet of Ministers of the Republic of Azerbaijan dated November 27, 2019, a decision has been made to recall the above-mentioned medicinal products.

ShareTweetShare
AEM

© 2022 AEM - Analitik Ekspertiza Mərkəzi .

Useful links

  • About Us
  • Contact
  • Rates

Follow us

  • AZAZ
  • RURU
No Result
View All Result
  • About Us
  • Import
    • Documents
    • Letter samples
  • Control
    • Control on Medicines
    • Legislation
  • Registration
    • Department of Registration
    • Legislation
  • Laboratory
    • About the Quality Control Laboratory
  • Pharmacovigilance
    • General information
    • Legislation
    • Information for healthcare professionals
    • Information for Patients
    • Pharmacovigilance dictionary
    • Reporting forms
    • Online reporting
    • Contacts
    • For MAH
    • Medicines under additional monitoring
  • Private medical institutions
    • Legislation
  • FS
    • Expertise of FS
    • Result of the Expertise of FS
  • Medical devices
    • Application form
    • MD Documents
    • Results of examination of medical devices
    • Legislation
  • Rates
  • Contact

© 2022 AEM - Analitik Ekspertiza Mərkəzi .

Accessibility

Content Scaling
Default
Text Magnifier
Dyslexia Friendly
Highlight Links
Font Sizing
Default
Left Aligned
Center Aligned
Right Aligned
Dark Contrast
Monochrome
High Saturation
Adjust Text Colors
Adjust Title Colors
Adjust Background Colors
Hide Images
Reading Guide
Reading Mask
Highlight Hover
Big Dark Cursor
Big Light Cursor